InvestorsHub Logo
Followers 52
Posts 2230
Boards Moderated 0
Alias Born 07/06/2011

Re: loanranger post# 146181

Friday, 02/23/2024 12:17:53 PM

Friday, February 23, 2024 12:17:53 PM

Post# of 146201
Agree it's not clear what Theracour is doing with the money recently, other than lining Diwan's pocket and supporting his private company. I guess working on manufacturing for upcoming Phase II? It would be nice if we had a bit more detailed description somewhere to see what NNVC investors are getting for their Theracour "investment." All the development work seems mostly done in terms of coming up with the backbone, appropriate ligands and linkages, and figuring out how to put it all together. They did report scaling up the batch size for future trials. It would be nice to hear the manufacturing cost per dose, Diwan salary at Theracour, number of personnel working at Theracour on behalf of NNVC, and other details that are obscured by listing a lump sum / Diwan slush fund / Theracour "development costs." Developing what, exactly?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News